Caroline is a commercial leader at GSK with over a decade of experience in traditional marketing and sales roles across multiple disease areas. She has built her career at the intersection of commercial strategy and execution, with a strong track record in developing teams and preparing organizations for successful product launches. Over the past two years, she has increasingly focused on the impact of artificial intelligence on the pharmaceutical industry, deliberately immersing herself in the tech ecosystem to better understand emerging developments. While not a technologist by background, Caroline brings a commercial lens to these changes, translating how AI is reshaping decision making, operating models, and the roles of marketing, sales, medical, and market access functions in pharma. Caroline Schwaer | LinkedIn
MedTech, healthcare and AI strategist & governance expert with a proven track record in digital transformation, driving growth, deep change, and restructuring initiatives for governments, organizations, and startups. My experience spans working with investors, boards, ministries, blue-chip multinationals, patient groups and scale-ups globally — including the USA, GCC, India, and APAC — across sectors such as AI, GenAI, ethics, value-based healthcare, digital health, ICT/IV and innovation.
Elliot Leavy is a strategist and speaker at the coalface of artificial intelligence, helping organisations translate agentic AI into scalable business value. As the founder of Acquainted, Europe’s first Generative AI consultancy, he advises global institutions on navigating the Intelligence Age. Elliot is also the author of the Machinepower Index, a definitive framework for assessing national AI sovereignty. By bridging geopolitical strategy with practical implementation, he provides a pragmatic roadmap for leaders looking to lead in the Age of AI.
Kaity Kalkbrenner is a healthcare analytics and strategy leader with more than 15 years of experience helping life sciences organizations turn data into strategic advantage. She has been an active shaper of AI enablement at Real Chemistry and across the healthcare communications industry, advancing how insight, analytics, and technology drive decision‑making. Today, Kaity leads Real Chemistry’s Swiss office, bringing the firm’s global capabilities to both local and international clients navigating complex scientific and commercial challenges.
Brandon is a scientific communications strategist and entrepreneur with a 20-year history in the healthcare industry, bridging the realms of art, science, and education. His foundation in medicine began with earning a Master of Science in Medical Illustration at Augusta University (formerly the Medical College of Georgia). In the 2 decades that followed, he developed and led creative teams that specialized in translating complex biomedical concepts into clear, compelling visual narratives and industry-defining educational experiences. His passions for health, technology, and art have also led to creative innovations in the use of AI to facilitate dialog between patients, caregivers, and healthcare professionals.Currently, as President, Europe, at Real Chemistry, Brandon oversees the agency's European presence, including locations in Zurich, Switzerland and Munich, Germany.
Explore the near-term trends shaping the AI landscape right now: the rise of world models and synthetic data, the acceleration of robotics, the emergence of agents and agentic workflows, the evolution of the agentic organisation, and the transformation of commerce, content and user interfaces through generative systems.
Pharma organizations are investing heavily in AI, often focusing on internal efficiency, content production, and pilot use cases. But the real disruption is happening outside the organization. This session shifts the lens from internal optimization to external value creation. We will explore how AI is transforming the interface between healthcare professionals and the care system, reshaping how information is accessed, trusted, and acted upon. Where is value being created, where budgets are shifting, and what this means for the future roles of marketing, sales, medical, and market access teams in pharma.
Examples of healthcare professionals and patient advocates using AI to improve clinical practice, research, and patient outcomes.
This event is for phama, biotech, and medtech professionals in Medical Affairs, Brand & Commercial, RWE & Data, Medical Communications/Publications, or Patient Engagement. If your role depends on making complex science resonate across stakeholders, this evening is for you.
National Museum Zürich. The striking ensemble comprises a fairy-tale castle with a stunning modern extension.
